TY - JOUR
T1 - Concentrations of Circulating Phylloquinone, but Not Cerebral Menaquinone-4, Are Positively Correlated with a Wide Range of Cognitive Measures
T2 - Exploratory Findings in Centenarians
AU - Tanprasertsuk, Jirayu
AU - Ferland, Guylaine
AU - Johnson, Mary Ann
AU - Poon, Leonard W.
AU - Scott, Tammy M.
AU - Barbey, Aron K.
AU - Barger, Kathryn
AU - Wang, Xiang Dong
AU - Johnson, Elizabeth J.
N1 - Funding Information:
Vitamin K analysis was funded by Abbott Nutrition. Author disclosures: JT, GF, MAJ, LWP, TMS, AKB, KB, X-DW, and EJJ, no conflicts of interest. Supplemental Figures 1–4 and Supplemental Tables 1 and 2 are available from the “Supplementary data” link in the online posting of the article and from the same link in the online table of contents at https://academic.oup.com/jn. Address correspondence to EJJ (e-mail: [email protected]) Abbreviations used: BDS, Behavioral Dyscontrol Scale; BNT, Boston Naming Test; CERAD, Consortium to Establish a Registry for Alzheimer’s Disease; COWAT, Controlled Oral Word Association Test; CP, Constructional Praxis; DAFS, Direct Assessment of Functional Status; FC, frontal cortex; FDR, false discovery rate; FOME, Fuld Object Memory Evaluation; GCS, Georgia Centenarian Study; GDS, Global Deterioration Scale; GDSSF, Geriatric Depression Scale–Short Form; LOD, limit of detection; MK, menaquinone; MMSE, Mini-Mental State Examination; PK, phylloquinone; SIB, Severe Impairment Battery; TC, temporal cortex; VF, Verbal Fluency; VK, vitamin K; VKDP, vitamin K-dependent protein; WAIS, Wechsler Adult Intelligence Scale; WLMT, Word List Memory Test.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - Background: Vitamin K (VK) exists in the form of phylloquinone (PK) and menaquinones (MKs). Roles of VK on cognitive health in the elderly are emerging, but there is limited evidence on VK uptake and metabolism in human brain. Objectives: The primary objective of this study was to characterize VK distribution in brains of an elderly population with varied cognitive function. In addition, associations among circulating (a biomarker of VK intake) and cerebral VK concentrations and cognition were investigated. Methods: Serum or plasma (n = 27) and brain samples from the frontal cortex (FC; n = 46) and the temporal cortex (TC; n = 33) were acquired from 48 decedents (aged 98-107 y; 25 demented and 23 nondemented) enrolled in the Georgia Centenarian Study. Both circulating and brain VK concentrations were measured using HPLC with fluorescence detection. Cognitive assessment was performed within 1 y prior to mortality. Partial correlations between serum/plasma or cerebral VK concentrations and cognitive function were performed, adjusting for covariates and separating by dementia and antithrombotic use. Results: MK-4 was the predominant vitamer in both FC (mean ± SD = 4.92 ± 2.31 pmol/g, ≥89.15% ± 5.09% of total VK) and TC (4.60 ± 2.11 pmol/g, ≥89.71% ± 4.43% of total VK) regardless of cognitive status. Antithrombotic users had 34.0% and 53.9% lower MK-4 concentrations in FC (P < 0.05) and TC (P < 0.001), respectively. Circulating PK was not correlated with cerebral MK-4 or total VK concentrations. Circulating PK concentrations were significantly associated with a wide range of cognitive measures in nondemented centenarians (P < 0.05). In contrast, cerebral MK-4 concentrations were not associated with cognitive performance, either before or after exclusion of antithrombotic users. Conclusions: Circulating VK concentrations are not related to cerebral MK-4 concentrations in centenarians. Cerebral MK-4 concentrations are tightly regulated over a range of VK intakes and cognitive function. Circulating PK may reflect intake of VK-rich foods containing other dietary components beneficial to cognitive health. Further investigation of VK uptake and metabolism in the brain is warranted.
AB - Background: Vitamin K (VK) exists in the form of phylloquinone (PK) and menaquinones (MKs). Roles of VK on cognitive health in the elderly are emerging, but there is limited evidence on VK uptake and metabolism in human brain. Objectives: The primary objective of this study was to characterize VK distribution in brains of an elderly population with varied cognitive function. In addition, associations among circulating (a biomarker of VK intake) and cerebral VK concentrations and cognition were investigated. Methods: Serum or plasma (n = 27) and brain samples from the frontal cortex (FC; n = 46) and the temporal cortex (TC; n = 33) were acquired from 48 decedents (aged 98-107 y; 25 demented and 23 nondemented) enrolled in the Georgia Centenarian Study. Both circulating and brain VK concentrations were measured using HPLC with fluorescence detection. Cognitive assessment was performed within 1 y prior to mortality. Partial correlations between serum/plasma or cerebral VK concentrations and cognitive function were performed, adjusting for covariates and separating by dementia and antithrombotic use. Results: MK-4 was the predominant vitamer in both FC (mean ± SD = 4.92 ± 2.31 pmol/g, ≥89.15% ± 5.09% of total VK) and TC (4.60 ± 2.11 pmol/g, ≥89.71% ± 4.43% of total VK) regardless of cognitive status. Antithrombotic users had 34.0% and 53.9% lower MK-4 concentrations in FC (P < 0.05) and TC (P < 0.001), respectively. Circulating PK was not correlated with cerebral MK-4 or total VK concentrations. Circulating PK concentrations were significantly associated with a wide range of cognitive measures in nondemented centenarians (P < 0.05). In contrast, cerebral MK-4 concentrations were not associated with cognitive performance, either before or after exclusion of antithrombotic users. Conclusions: Circulating VK concentrations are not related to cerebral MK-4 concentrations in centenarians. Cerebral MK-4 concentrations are tightly regulated over a range of VK intakes and cognitive function. Circulating PK may reflect intake of VK-rich foods containing other dietary components beneficial to cognitive health. Further investigation of VK uptake and metabolism in the brain is warranted.
KW - Vitamin K
KW - cognition
KW - menaquinone
KW - older adults
KW - phylloquinone
UR - http://www.scopus.com/inward/record.url?scp=85077665903&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077665903&partnerID=8YFLogxK
U2 - 10.1093/jn/nxz200
DO - 10.1093/jn/nxz200
M3 - Article
C2 - 31504672
AN - SCOPUS:85077665903
SN - 0022-3166
VL - 150
SP - 82
EP - 90
JO - Journal of Nutrition
JF - Journal of Nutrition
IS - 1
ER -